Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for C9257. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
17
Median % of Medicare
--
Rate range
$0.98 - $2.13
C9257 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $1.74* | -- | -- | 2026 |
| Arizona | $1.74 | -- | -- | 2026 |
| Iowa | $1.68 | -- | -- | 2024 |
| Idaho | $1.67 | -- | Not required | 2025 |
| Indiana | $2.09 | -- | -- | 2018 |
| Kansas | $1.99 | -- | -- | 2021 |
| Kentucky | $1.84 | -- | -- | 2026 |
| Maine | $1.87 | -- | -- | 2026 |
| Michigan | $0.98 | -- | -- | 2026 |
| Minnesota | $1.51 | -- | -- | 2026 |
| Montana | $1.86 | -- | -- | 2026 |
| Nebraska | $2.13 | -- | -- | 2026 |
| New Mexico | $1.51 | -- | -- | 2026 |
| Rhode Island | $1.92 | -- | -- | 2026 |
| Texas | $2.03* | -- | -- | 2019 |
| Utah | $1.95* | -- | Not required | 2026 |
| Wyoming | $1.94 | -- | -- | 2021 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 38 codes from C9047 to C9901 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for C9257?
17 state Medicaid programs publish a fee-for-service rate for C9257 (injection, bevacizumab, 0.25 mg), ranging from $0.98 in Michigan to $2.13 in Nebraska. The full table on this page lists every publishing state's current rate.
Which state pays the most for C9257?
Nebraska publishes the highest Medicaid rate for C9257 at $2.13. Michigan publishes the lowest at $0.98.
Does C9257 require prior authorization under Medicaid?
No publishing state flags C9257 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.